USPTO serial 79293510
SYNBOT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 8, 2021
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SYNBOT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; biological preparations for use in industry and science; biological preparations for use in manufacture; biological preparations for use in science; biological preparation for use in cell cultures other than for medical or veterinary use; blood culture media being cell culture media for scientific use; biochemicals, namely precursors for in vitro genetic engineering use; chemical preparations for use in DNA analysis for scientific and research purposes; enzymes for use as biochemical catalysts for scientific and research purposes; biochemicals, namely polypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use; diagnostic test kits for use in science, comprised of patch preparations in the nature of diagnostic reagents; diagnostic test kits for scientific use, comprised of reagents, processing chemicals; biochemicals for in vitro and in vivo use in industry and science; molecular biological products in the nature of reagents for use in industry and science; plasmids for use in industry and science; chromosomes being DNA molecules, DNA polymerase for use in industry and science; Diagnostic test kits for use in science, comprised of patch preparations being diagnostic reagents | ACTIVE | — |
| 005 | Preparations for detecting genetic predispositions for medical purposes; biological implants, namely, a vital processed human or animal connective tissue; biological bone, skin tissue for implantation; biological adjuvants for medical purposes; biological reagents for medical use; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes for the treatment of cancer and the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; bone growth media consisting of biological materials for medical purposes; human plasma protein being blood plasma; blood plasma; blood components being cord blood, blood, blood plasma for medical purposes; blood substitutes for human, veterinary use; blood protein fractions for medical purposes, namely, for use in cell culture products and diagnostic applications; DNA synthesis inhibitors for medical use; chemical preparations for use in DNA analysis for medical purposes for the treatment of cancer and infectious diseases; cells for medical use; diagnostic medical reagents for medical use in diagnosing inflammatory, infections, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; diagnostic test kits for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological endocrine, autoimmune and genetic diseases and cancer, comprised of reagents, processing chemicals and transdermal patches; medical diagnostic test kits comprised of medical diagnostic reagents for detecting pathogens in the environment | ACTIVE | — |
| 009 | DNA microarrays; DNA chips; biochip sensors for research or scientific purposes; bioreactor for cell culturing; laboratory equipment, namely, laboratory apparatus and laboratory instruments for use in protein purification, DNA analysis and analysis of blood and biological tissue cultures; laboratory apparatus and instruments, namely, apparatus for sieve tests, the detection of analytes in samples and the identification of the sample type, together with measurement pattern and kits for building and screening of molecular systems, comprised of DNA microarrays, as well as parts for it, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, urine analyzers, immunoassay analyzers, hematology analyzers | ACTIVE | — |
| 042 | Genetic research; genetic fingerprinting for scientific or medical research purposes; scientific research relating to genetics; scientific research in the field of genetics and genetic engineering; biological laboratory services; biological cloning services; biological research, clinical research and medical research, namely, conducting clinical trials for others as well as medical and clinical research in the field of cancer and infectious diseases; scientific laboratory services, namely, services of a chemical and/or biological laboratory; blood analysis services; genetic engineering services; DNA screening for scientific research purposes; research and development in the field of microorganisms and cells; scientific services relating to the isolation and cultivation of human tissues and cells; research and development services for third parties in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental testing processes and industrial quality control processes; chemical sieve analysis; scientific and technological services, namely, research and design services in the field of diagnostic chemicals; industrial analysis in the nature of analysis of industrial fluids; industrial research in the field of diagnostic chemicals; services of an industrial designer; quality control for others; authentication services in the field of diagnostic chemicals, measuring apparatus; design and development of computer hardware and software; scientific and product research in the area of textile dyes; product , scientific, and biomedical research, in the area of textile dyes consisting of bacteria | ACTIVE | — |
| 044 | Medical and health assessment services relating to naked DNA, genetics and genetic testing for medical purposes; genetic counselling; blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical diagnostic services being the execution of tests and analysis; execution of medical tests for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Synbionik GmbH
- Other trademarks owned by Synbionik GmbH
- Other trademarks owned by Synbionik GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SYNBOT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 25, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 28, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 28, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 30, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 30, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 30, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 17, 2021 | ALIE | ASSIGNED TO LIE | — |
| Feb 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 15, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 23, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |